MedPath

White Tea for Prevention of Chemotherapy Induced Mucositis

Not Applicable
Completed
Conditions
Oral Mucositis
Interventions
Other: White tea
Other: Salt water with soda
Registration Number
NCT04440930
Lead Sponsor
Vejle Hospital
Brief Summary

The aim of this study is to determine the effectiveness of mouthwash with white tea in the prevention of paclitaxel induced oral mucositis in women with breast cancer.

Detailed Description

Oral mucositis is a common side effect from paclitaxel treatment. It can be very painful and compromise nutrition and oral hygiene, and it may increase the risk of infection. Although oral mucositis is a common side effect to chemotherapy, no available treatment is yet available that can effectively prevent or treat oral mucositis.

Based on the knowledge that white tea has anti-inflammatory, anti-oxidant and anti-microbial effect, the current study aims to assess the effect of mouth wash with white tea on paclitaxel induced oral mucositis in women with breast cancer.

This study is a phase II randomized controlled trial in which eligible patients will be allocated to a control group (CG) and a study group (SG). The CG will use salt water with soda for mouthwash eight to ten times a day and the SG will use white tea for mouthwash five to six times a day.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
88
Inclusion Criteria
  • Woman with breast cancer
  • Planned neoadjuvant or adjuvant paclitaxel treatment
  • Age ≥ 18 years
  • Understand and speak Danish
  • Written and orally informed consent
Exclusion Criteria
  • Palliative treatment with paclitaxel

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
White teaWhite tea-
Salt water with sodaSalt water with soda-
Primary Outcome Measures
NameTimeMethod
Incidence of oral mucositis grade 2 or higher as measured by the Revised Oral Assessment Guide.up to nine weeks

Nine categories are included in the Revised Oral Assessment Guide tool: voice, lips, mucous, tongue, gums, teeth, saliva, denture and swallowing. Each category is described and rated according to a score of 1 (healthy) to 3 (severe problems).

Secondary Outcome Measures
NameTimeMethod
Frequency of daily tooth brushingsonce a week over a period of nine weeks

Number of daily tooth brushings will be registered

Pain intensity in the oral cavity as measured on the Numeric Rating Scale (NRS).Once a week over a period of nine weeks

Numeric Rating Scale 0-10; 0=no pain, 10=worst possible pain

Date of onset of oral mucositis grade 2 or higher as measured by Revised Oral Assessment Guide.Once a week until oral mucositis occurs up to nine weeks

Nine categories are included in the Revised Oral Assessment Guide tool: voice, lips, mucous, tongue, gums, teeth, saliva, denture and swallowing. Each category is described and rated according to a score of 1 (healthy) to 3 (severe problems).

Frequency of daily mouthwashesonce a week over a period of nine weeks

Number of daily mouthwashes will be registered

Trial Locations

Locations (1)

Department of Oncology, Vejle Hospital

🇩🇰

Vejle, Denmark

© Copyright 2025. All Rights Reserved by MedPath